Home > News > BioCrystal and Crystalplex in Broad Cross-Licensing Pact
November 1st, 2004
BioCrystal and Crystalplex in Broad Cross-Licensing Pact
Abstract:
Two emerging nanotechnology companies announced a broad cross-licensing agreement that will extend the market reach and technical utility of their fluorescent biomolecular assaying platforms.
Source:
prnewswire
Bookmark:
| Related Links |
| Related News Press |
Possible Futures
Rice research could make weird AI images a thing of the past: New diffusion model approach solves the aspect ratio problem September 13th, 2024
New discovery aims to improve the design of microelectronic devices September 13th, 2024
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over 14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Nanomedicine
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024
Announcements
New discovery aims to improve the design of microelectronic devices September 13th, 2024
New method in the fight against forever chemicals September 13th, 2024
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||